Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease

Topic: Amyloid, tau and blood-test diagnosis

Objective To test the hypothesis that the APOE epsilon4 allele is associated with the clinical manifestations of AD through an association with the pathologic hallmarks of disease. Methods Participants were older Catholic nuns, priests, and brothers who agreed to annual neurologic and neuropsychological evaluation for AD and other common neurologic conditions and brain autopsy at the time of death. There were 77 persons without dementia and 51 with probable AD; 38 participants had one or more epsilon4 alleles. Results In logistic regression analyses, controlling for age, sex, and education, the epsilon4 allele was strongly associated with the likelihood of clinical AD (odds = 3.46, 95% CI = 1.44 to 8.33). However, controlling for the effect of AD pathology, the association of the epsilon allele with clinical AD was reduced by >50% and was no longer significant (odds = 1.58, 95% CI = 0.56 to 4.43). Similarly, in linear regression analyses, controlling for age, sex, and education, the epsilon4 allele was strongly associated with level of cognitive function proximate to death (regression coefficient = -0.477, p = 0.005). However, after controlling for the effect of AD pathology, the association of the epsilon4 allele with level of cognition was reduced by >80% and was no longer significant (regression coefficient = -0.093). Similar results were found in analyses using separate measures of neuritic plaques, diffuse plaques, and neurofibrillary tangles, and in analyses of five different cognitive systems (episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability). Conclusions The APOE epsilon4 allele appears to be associated with the clinical manifestations of AD through an association with the pathologic hallmarks of AD rather than another mechanism.

@article{bennett2003-12552039,
  author  = {Bennett, D. A. and Wilson, R. S. and Schneider, J. A. and Evans, D. A. and Aggarwal, N. T. and Arnold, S. E. and Cochran, E. J. and Berry-Kravis, E. and others},
  title   = {{Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease}},
  journal = {Neurology},
  year    = {2003},
  doi     = {10.1212/01.wnl.0000042478.08543.f7},
  pmid    = {12552039},
  url     = {https://doi.org/10.1212/01.wnl.0000042478.08543.f7}
}

Key findings

• Objective To test the hypothesis that the APOE epsilon4 allele is associated with the clinical manifestations of AD through an association with the pathologic hallmarks of disease.
• Results In logistic regression analyses, controlling for age, sex, and education, the epsilon4 allele was strongly associated with the likelihood of clinical AD (odds = 3.46, 95% CI = 1.44 to 8.33).
• However, controlling for the effect of AD pathology, the association of the epsilon allele with clinical AD was reduced by >50% and was no longer significant (odds = 1.58, 95% CI = 0.56 to 4.43).
• Similarly, in linear regression analyses, controlling for age, sex, and education, the epsilon4 allele was strongly associated with level of cognitive function proximate to death (regression coefficient = -0.477, p = 0.005).
• However, after controlling for the effect of AD pathology, the association of the epsilon4 allele with level of cognition was reduced by >80% and was no longer significant (regression coefficient = -0.093).

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Participants77
• Evidence strengthLow

Read the original

• DOI: 10.1212/01.wnl.0000042478.08543.f7
• PubMed: 12552039
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Genetics

• Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Annals of internal medicine · 2002-08-01 · usefulness score 58/100
• The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons Stroke · 2005-03-17 · usefulness score 55/100
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele The American journal of pathology · 2003-01-01 · usefulness score 36/100
• Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease The American journal of pathology · 1996-06-01 · usefulness score 36/100
• Does apolipoprotein E genotype modify the clinical expression of ALS? European journal of neurology · 2010-09-28 · usefulness score 38/100
• The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA · 1998-03-01 · usefulness score 70/100

Also tagged “pathology”

10 studies in the library carry the topic tag “pathology”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 10 tagged studies.

• A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology Nature medicine · 2026-01-05 · usefulness score 60/100 · Biomarkers
• CSF metabolites associated with biomarkers of Alzheimer's disease pathology Frontiers in aging neuroscience · 2023-08-30 · usefulness score 52/100 · Biomarkers
• Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology Experimental neurology · 1994-02-01 · usefulness score 36/100 · Biomarkers

Similar studies

• Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases 1993 · Genetics
• Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease 1996 · Genetics
• Apolipoprotein E in Alzheimer's disease: an update 2014 · Genetics
• Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia 1994 · Genetics
• Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond 1999 · Genetics
• Apolipoprotein E and Alzheimer disease 2006 · Genetics

More on Genetics

• A review that covers this ground Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology Molecular psychiatry · 2013-02-12 · usefulness score 72/100
• Newest in this subject APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model Research Square · 2026-10-31 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Integrative systems biology identifies shared neuroimmune co-expression programmes across pulmonary tuberculosis and Alzheimer's disease Research Square · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Genetics →